(19)
(11) EP 2 191 808 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
07.08.2013 Bulletin 2013/32

(45) Mention of the grant of the patent:
26.06.2013 Bulletin 2013/26

(21) Application number: 09252710.0

(22) Date of filing: 01.12.2009
(51) International Patent Classification (IPC): 
A61J 11/00(2006.01)

(54)

Textured stimulus nipple

Texturierter Stimulationsnippel

Mamelon stimulant texturé

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 01.12.2008 US 325850

(43) Date of publication of application:
02.06.2010 Bulletin 2010/22

(73) Proprietor: Innara Health, Inc.
Shawnee, KS 66227-3142 (US)

(72) Inventors:
  • STALLING,David L.
    Lenexa, Kansas 66220 (US)
  • LITSCHER, Mike.
    Lenexa, Kansas 66220 (US)

(74) Representative: Robertson, James Alexander 
Marks & Clerk LLP 90 Long Acre
London WC2E 9RA
London WC2E 9RA (GB)


(56) References cited: : 
EP-A1- 2 082 721
WO-A1-97/04736
WO-A1-2008/020349
 WO-A1-01/00136
WO-A1-2006/033801
US-A1- 2004 220 618
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).